Neurovascular frataxin and cognitive dysfunction in sickle cell disease
镰状细胞病中的神经血管 frataxin 和认知功能障碍
基本信息
- 批准号:10810463
- 负责人:
- 金额:$ 23.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-25 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAdultAffectAlzheimer&aposs DiseaseAnisotropyAreaAstrocytesBehavioralBiochemicalBiogenesisBiological AssayBlood VesselsBlood flowBone MarrowBone Marrow TransplantationBrainCalciumCellsCerebral HypoxiaCerebral InfarctionCerebral IschemiaCerebrovascular systemCerebrumChimera organismClinicalClinical ResearchCognitiveDataDevelopmentDiffusionDiffusion Magnetic Resonance ImagingDiscriminationDoxorubicinEventExhibitsExposure toFoundationsFriedreich AtaxiaFunctional disorderFutureGlial Fibrillary Acidic ProteinHealthHemoglobinHemolysisHistopathologyHomeostasisHumanHypoxemiaHypoxiaHypoxia Inducible FactorImmunofluorescence ImmunologicImpaired cognitionIndividualInflammationInjuryIronIschemiaKnock-outKnowledgeLesionLinkMagnetic Resonance ImagingMemoryMitochondriaMitochondrial ProteinsMouse StrainsMusMutateMyelin Basic ProteinsNerve DegenerationNeurofilament-HNeurogliaNeuronsPathogenesisPathway interactionsPatientsPhenocopyPreventionProteinsResearchRoleShort-Term MemorySickle Cell AnemiaSickle HemoglobinSmall Interfering RNAStainsStrokeSulfurTestingTherapeuticTissuesTransgenic OrganismsTransplantationWhite Matter HyperintensityWild Type Mouseage relatedaxon injuryburden of illnesscerebral microvasculaturecerebrovascularcerebrovascular lesioncognitive functioncognitive testingexecutive functionexperienceexperimental studyfrataxinhemoglobin polymerimprovedindexinginnovationinsightmixed dementiamouse modelneurovascularnew therapeutic targetnovelobject recognitionpre-clinicalprocessing speedprototyperesiliencerestorationsicklingspatial memorytherapeutic targettranscription factorvascular cognitive impairment and dementiawhite matterwhite matter injury
项目摘要
Cerebrovascular injuries, including overt stroke, silent cerebral infarction involving diffused white matter neuroaxonal lesions are integrated within the pathogenesis of vascular contributions to cognitive impairment and dementia (VCID). A significant disease burden in sickle cell disease (SCD) includes cognitive decline affecting >50% of the adult patients impacting memory and executive functioning primarily associated with white matter hyperintensities. Occlusions of the cerebral microvessels due to sickle hemoglobin polymerization results in hypoxia and subsequent reoxygenation (H/R) leading to ischemic tissue damage. The present proposal, set to determine the mechanistic link between H/R within the cerebrovascular space and the white matter hyperintensities instigating VCID in SCD setting, thus create a prototype to fill the knowledge gap in the pathogenesis of VCID. Using a preclinical mouse model of SCD, we found that microstructural white matter hyperintensities, identified by magnetic resonance imaging-based diffusion tensor imaging and histopathology are substantially abundant in sickle (SS) mice compared to normal (AA) mice. The white matter hyperintensities in the SS mice were associated with cognitive decline and activation of astrocytes, the modified glial cells connecting cerebral microvasculature and the neurons. Frataxin (FXN), a mitochondrial protein responsible for iron-sulfer clustering, regulates astrocyte function and is associated with neurodegeneration in Friedreich’s ataxia. Our pilot data showed that expression of FXN is reduced in the astrocytes concomitant with an increase in hypoxia inducible factor-1a (HIF-1a), a homeostatic regulatory transcription factor that is elevated during H/R events. The overarching scientific hypothesis is that elevated HIF-1a inhibits astrocytic frataxin and promotes white matter injury and VCID in SCD. In Aim 1, we will be performing diffusion tensor imaging and immunofluorescence experiments to assess microstructural damage, neuronal calcium accumulation and astrocyte activation in H/R-challenged SS and AA mice. Using bone marrow trasplantation (BMT), we will be assessing the role of FXN in the development of white matter injury and cognitive impairment following H/R injury in the sickle chimera mice lacking expression of astrocytic FXN. In Aim 2, a sickle chimera mice with targeted deletion of HIF-1a in the astrocytes will be generated using BMT. The new sickle chimera mice will be used to determine whether HIF-1a is critical for inhibition of FXN promoting white matter injury and cognitive decline. Successful completion of the study will identify FXN as a promising therapeutic target for white matter protection that may help provide resilience against VCID. Since underlying inflammation and ischemia often accelerate age-related pathophysiology in SCD, this study will lay the foundation to identify the causal link between ischemia and astrocyte function in the pathogenesis of progressive VCID, which also has the potential to generalize beyond VCID in SCD to common mixed dementias such as clinical Alzheimer’s disease.
脑血管损伤,包括涉及扩散的白质神经性病变的明显中风,无声的脑梗塞,在对认知障碍和痴呆(VCID)的血管贡献的发病机理中整合了。镰状细胞疾病(SCD)中的一种大量疾病包括影响记忆和高管发挥作用的成年患者的认知能力下降,主要与白质超强度有关。由于镰状血红蛋白聚合而引起的脑微血管的遮挡导致缺氧和随后的重氧(H/R)导致缺血性组织损伤。目前的提案旨在确定脑血管空间内的H/R之间的机械联系,而白质超强度在SCD设置中煽动VCID,从而创建了一个原型,以填补VCID发病机理中的知识差距。使用SCD的临床前小鼠模型,我们发现与正常(AA)小鼠相比,镰刀(SS)小鼠相比,基于磁共振成像的扩散张量成像和组织病理学的微结构白质高强度基本上很丰富。 SS小鼠中的白质高强度与星形胶质细胞的认知下降和激活有关,修饰的神经胶质细胞连接了脑微脉管和神经元。 Frataxin(FXN)是一种负责铁硫簇聚集的线粒体蛋白,可调节星形胶质细胞功能,并与Friedreich的共济失调中的神经变性有关。我们的试点数据表明,在星形胶质细胞中,FXN的表达与缺氧诱导因子1a(HIF-1A)的增加降低,这是H/R事件期间升高的稳态调节转录因子。总体科学假设是,升高的HIF-1A抑制星形胶质细胞frataxin并促进SCD中的白质损伤和VCID。在AIM 1中,我们将进行扩散张量成像和免疫荧光实验,以评估H/R挑战的SS和AA小鼠中的微观结构损伤,神经元钙的积累和星形胶质细胞激活。使用骨髓trasplantation(BMT),我们将评估FXN在缺乏星形胶质细胞FXN表达的镰状嵌合小鼠中H/R损伤后H/R损伤后的白质损伤和认知障碍的作用。在AIM 2中,将使用BMT产生具有星形胶质细胞中HIF-1A靶向缺失的镰刀嵌合体小鼠。新的镰刀嵌合体小鼠将用于确定HIF-1A对于抑制FXN促进白质损伤和认知能力下降是否至关重要。该研究的成功完成将确定FXN是对白质保护的有希望的治疗靶标,这可能有助于为VCID提供弹性。由于SCD中的潜在炎症和缺血通常会加速与年龄相关的病理生理学,因此这项研究将奠定基础,以确定渐进VCID发病机理中缺血和星形胶质细胞功能之间的因果关系,这也有可能使SCD超出SCD的潜力,以使SCD超出SCD,例如常见的混合痴呆症,例如临床上的Alzheimerers病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rimi Hazra其他文献
Rimi Hazra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
去泛素化酶USP5调控P53通路在伴E2A-PBX1成人ALL的致病机制研究
- 批准号:81900151
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
核基质结合区蛋白SATB1调控CCR7抑制急性T淋巴细胞白血病中枢浸润的作用与机制
- 批准号:81870113
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
成人及儿童急性淋巴细胞白血病的基因组转录组生物信息学分析方法建立及数据分析
- 批准号:81570122
- 批准年份:2015
- 资助金额:60.0 万元
- 项目类别:面上项目
NR3C1基因突变在成人急性淋巴细胞白血病耐药与复发中的作用与机制研究
- 批准号:81470309
- 批准年份:2014
- 资助金额:75.0 万元
- 项目类别:面上项目
儿童和成人急性T淋巴细胞白血病中miRNA和转录因子共调控网络的差异性研究
- 批准号:31270885
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
相似海外基金
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 23.08万 - 项目类别:
Role of Creatine Metabolism in Necrotizing Enterocolitis
肌酸代谢在坏死性小肠结肠炎中的作用
- 批准号:
10724729 - 财政年份:2023
- 资助金额:
$ 23.08万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 23.08万 - 项目类别: